AMGN - Amgen Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
26,323,000
26,323,000
25,979,000
25,424,000
23,362,000
Cost of revenue
6,406,000
6,406,000
6,454,000
6,159,000
4,356,000
Gross profit
19,917,000
19,917,000
19,525,000
19,265,000
19,006,000
Operating expenses
Research development
4,434,000
4,434,000
4,819,000
4,207,000
4,116,000
Selling general and administrative
5,414,000
5,414,000
5,368,000
5,730,000
5,150,000
Total operating expenses
10,351,000
10,351,000
10,381,000
10,126,000
9,332,000
Operating income or loss
9,566,000
9,566,000
9,144,000
9,139,000
9,674,000
Interest expense
1,406,000
1,406,000
1,197,000
1,262,000
1,289,000
Total other income/expenses net
-814,000
-814,000
-1,246,000
-
-
Income before tax
7,346,000
7,346,000
6,701,000
8,133,000
9,138,000
Income tax expense
794,000
794,000
808,000
869,000
1,296,000
Income from continuing operations
6,552,000
6,552,000
5,893,000
7,264,000
7,842,000
Net income
6,552,000
6,552,000
5,893,000
7,264,000
7,842,000
Net income available to common shareholders
6,552,000
6,552,000
5,893,000
7,264,000
7,842,000
Basic EPS
-
12.18
10.34
12.40
12.96
Diluted EPS
-
12.11
10.28
12.31
12.88
Basic average shares
-
538,000
570,000
586,000
605,000
Diluted average shares
-
541,000
573,000
590,000
609,000
EBITDA
-
8,752,000
7,898,000
9,395,000
10,427,000